Spots Global Cancer Trial Database for Phase II Trial of LBH589 in Refractory Colorectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase II Trial of LBH589 in Refractory Colorectal Cancer
Official Title: Phase II Trial of LBH589 in Refractory Colorectal Cancer
Study ID: NCT00690677
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the effects of the study drug, LBH589, on patients with metastatic colorectal cancer that has continued to grow despite previous treatment.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Swedish Medical Center, Seattle, Washington, United States
Contact Details
Name: Philip Gold, MD
Affiliation: Swedish Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
